Physician profile
Nathan B Hirsch
NPI 1720196454
$1,616.92
in general payments reported to CMS, 2019-2025
23 companies · $74.15 in 2025
The $74.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $92.45 · 2021: $70.34 · 2022: $549 · 2023: $276 · 2024: $260 · 2025: $74.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $301.18 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $223.08 | 2019-2024 | |
| Abbvie INC. | $198.80 | 2019-2022 | |
| Daiichi Sankyo INC. | $162.83 | 2019-2022 | |
| Coopersurgical, INC. | $140.61 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $139.63 | 2023-2025 | |
| Astellas Pharma US INC | $76.86 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $70.76 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Myovant Sciences INC. | $43.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $33.98 | 2019 | |
| Sumitomo Pharma America, INC. | $29.84 | 2023 | Myfembree |
| Galderma Laboratories, L.P. | $27.78 | 2023 | |
| Davol INC. | $23.75 | 2019 | |
| Biogen, INC. | $21.75 | 2024 | Zurzuvae |
| Novo Nordisk INC | $16.40 | 2023 | Wegovy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.03 | 2023 | Accrufer |
| Mycovia Pharmaceuticals, INC. | $15.14 | 2023 | Vivjoa |
| Scynexis, INC. | $15.13 | 2022 | |
| Mission Pharmacal Company | $13.57 | 2019 | |
| Medicem INC. | $13.02 | 2021 | |
| Allergan, INC. | $11.48 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.05 | 2020 | |
| Organon LLC | $10.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.